BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1657203)

  • 21. Imaging with pentavalent [99mTc]DMSA in patients with medullary cancer of the thyroid.
    Hilditch TE; Murray T; Connell JM; McLellan AR; Reed NS
    J Nucl Med; 1988 Oct; 29(10):1746-7. PubMed ID: 2845025
    [No Abstract]   [Full Text] [Related]  

  • 22. Preparation of 99Tcm (V) DMSA.
    Sampson CB
    Nucl Med Commun; 1987 Mar; 8(3):184-5. PubMed ID: 3035444
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro and in vivo studies with pentavalent technetium-99m dimercaptosuccinic acid.
    Lam AS; Puncher MR; Blower PJ
    Eur J Nucl Med; 1996 Dec; 23(12):1575-82. PubMed ID: 8929310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of chromatographic methods for quality control of DMSA complexes with 99mTc and 188Re at (III) and (V) oxidation states.
    Garnuszek P; Pawlak D; Maurin M; Jankovic D; Karczmarczyk U; Mikołajczak R
    Nucl Med Rev Cent East Eur; 2012 Aug; 15(2):95-100. PubMed ID: 22936501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pentavalent Tc-99m DMSA scintigraphy. Prospective evaluation of its role in the management of patients with medullary carcinoma of the thyroid.
    Mojiminiyi OA; Udelsman R; Soper ND; Shepstone BJ; Dudley NE
    Clin Nucl Med; 1991 Apr; 16(4):259-62. PubMed ID: 1646098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pentavalent Tc-99m DMSA accumulation in a medullary carcinoma of the thyroid.
    Hirano T; Otake H; Watanabe N; Oriuchi N; Fukuda T; Endo K
    Clin Nucl Med; 1997 May; 22(5):339-40. PubMed ID: 9152545
    [No Abstract]   [Full Text] [Related]  

  • 27. Medullary carcinoma of the thyroid: management of persistent hypercalcitonaemia utilizing [99mTc] (v) dimercaptosuccinic acid scintigraphy.
    Udelsman R; Mojiminiyi OA; Soper ND; Buley ID; Shepstone BJ; Dudley NE
    Br J Surg; 1989 Dec; 76(12):1278-81. PubMed ID: 2557953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of radiopharmaceuticals MIBG and (V) DMSA in the diagnosis of medullary thyroid carcinoma.
    Verga U; Muratori F; Di Sacco G; Banfi F; Libroia A
    Henry Ford Hosp Med J; 1989; 37(3-4):175-7. PubMed ID: 2576958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solitary cold thyroid nodules -- a correlation of fine needle aspiration cytology with pentavalent technetium DMSA scanning and radionuclide perfusion scanning.
    Natarajan V; Jayaram G; Kakar A; Prakash R
    Malays J Pathol; 1994 Dec; 16(2):127-35. PubMed ID: 9053561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tc-99m(V) DMSA imaging. A new approach to studying metastases from breast carcinoma.
    Kashyap R; Babbar A; Sahai I; Prakash R; Soni NL; Chauhan UP
    Clin Nucl Med; 1992 Feb; 17(2):119-22. PubMed ID: 1314148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiopharmaceutical development of a freeze-dried kit formulation for the preparation of [99mTc-EDDA-HYNIC-D-Phe1, Tyr3]-octreotide, a somatostatin analog for tumor diagnosis.
    Guggenberg EV; Mikolajczak R; Janota B; Riccabona G; Decristoforo C
    J Pharm Sci; 2004 Oct; 93(10):2497-506. PubMed ID: 15349959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidental detection of papillary carcinoma of the thyroid by Tc-99m (V) DMSA tumor scintigraphy.
    Kobayashi H; Kotoura Y; Tsuboyama T; Hosono M; Sakahara H; Konishi J
    Clin Nucl Med; 1995 Jul; 20(7):638. PubMed ID: 7554673
    [No Abstract]   [Full Text] [Related]  

  • 33. Technetium-99m(V)-DMSA in the imaging of medullary thyroid carcinoma.
    J Nucl Med; 1987 Feb; 28(2):252-3. PubMed ID: 3027281
    [No Abstract]   [Full Text] [Related]  

  • 34. Detection of medullary carcinoma of thyroid, with liver metastasis, using 99mTc DMSA(V) scintigraphy.
    Shikare S; Bashir K; Menon PS; Bapat RD; Tilve GH
    J Postgrad Med; 1995; 41(1):12-3. PubMed ID: 10740693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP.
    Wulfrank DA; Schelstraete KH; Small F; Fallais CJ
    Clin Nucl Med; 1989 Aug; 14(8):588-93. PubMed ID: 2553315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Tc-99m(V) DMSA for imaging inflammatory lesions: an experimental study.
    Ercan MT; Gülaldi NC; Unsal IS; Aydin M; Peksoy I; Hasçelik Z
    Ann Nucl Med; 1996 Nov; 10(4):419-23. PubMed ID: 9006727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraosseous hemangiomatosis: technetium-99m(V)dimercaptosuccinic acid and technetium-99m-hydroxymethylene diphosphonate imaging.
    Kobayashi H; Shigeno C; Sakahara H; Hosono M; Hosono M; Yao ZS; Endo K; Konishi J
    J Nucl Med; 1994 Sep; 35(9):1482-4. PubMed ID: 8071696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pentavalent 99mTc DMSA: uptake into a variety of human rhabdomyosarcoma xenografts.
    Van der Wall H; Henderson D; Baker R; Murray IP
    In Vivo; 1997; 11(1):45-50. PubMed ID: 9067772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 111In-octreotide and 99mTc(V)-dimercaptosuccinic acid studies in the imaging of recurrent medullary thyroid carcinoma.
    Berná L; Cabezas R; Mora J; Torres G; Estorch M; Carrió I
    J Endocrinol; 1995 Feb; 144(2):339-45. PubMed ID: 7706986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tc-99m DMSA scintigraphy on patients with medullary thyroid carcinoma.
    Groth P; Unterspann S; Schwähn D; Stoll I; Reincke R
    Radiobiol Radiother (Berl); 1987; 28(5):642-4. PubMed ID: 2831560
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.